company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8695000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8695000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,170000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,212000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1885000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,510000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5918000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5918000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-99000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26552000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28843000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2192000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2192000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-8000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3734000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8321000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8321000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,175000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,328000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2086000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3161000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2571000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2571000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-61000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19499000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23348000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3788000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3788000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,512000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,512000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,512000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1729000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9578000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9578000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,162000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,320000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1963000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4825000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11958000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11958000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-110000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15122000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22438000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7206000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7206000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,847000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,847000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,847000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:16:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3905000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10259000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10259000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,157000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,466000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1966000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,199000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7471000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7471000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-86000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-63762000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22118000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-41730000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-41730000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,50743000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,50743000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,50743000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1542000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9554000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9554000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,160000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,451000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2053000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,422000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6468000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6468000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-175000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3642000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23457000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19640000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19640000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,74000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,74000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,74000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13246000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6359000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6359000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,167000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,339000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2099000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3756000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-205000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30448000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25538000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5115000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5115000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,212000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4901000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7268000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7268000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,168000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,272000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1383000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8312000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2867000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2867000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-218000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12853000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17820000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4749000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4749000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,108000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,108000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,108000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 13:41:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7724000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5728000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5728000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,166000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,218000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1224000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1893000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6013000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6013000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34652000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34300000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-397000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-397000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,396000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,396000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,396000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6014000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5790000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5790000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,166000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,202000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1404000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1141000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5159000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5159000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-100000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23065000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23035000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-130000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-130000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,537000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,537000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,537000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4752000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3478000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3478000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,160000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,197000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1450000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1894000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,223000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,223000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-360000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20858000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28315000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7097000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7097000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,635000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,635000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,635000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7955000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6885000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6885000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,147000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,231000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1329000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2840000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8018000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8018000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-68000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16573000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12910000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3731000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3731000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2247000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2247000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2247000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:56:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9502000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5450000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5450000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,158000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,225000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1378000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1604000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5293000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5293000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-281000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10951000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14510000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3278000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3278000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4137000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2247000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1890000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1890000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-125000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6145000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6145000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,140000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,169000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1391000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-69000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4514000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4514000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-46000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9637000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10964000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1281000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1281000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,69492000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1998000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,71490000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,71490000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68257000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8144000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8144000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,124000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,287000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2048000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4028000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1657000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1657000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-81733000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,79000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12745000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-68946000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-68946000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2495000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2015000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,480000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,480000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-70123000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7572000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7572000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,123000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,295000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1907000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16626000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,11379000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,11379000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-126000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16773000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20786000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3887000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3887000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,93786000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7585000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,101371000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,101371000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 16:32:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,116637000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6981000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6981000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,127000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,288000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2129000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4137000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8574000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8574000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-339000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50230000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29818000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20751000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20751000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1762000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1772000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1772000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27553000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7545000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7545000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,150000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,260000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2129000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-762000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5768000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5768000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-94000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-109382000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26001000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83475000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83475000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1178000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1178000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1178000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-88065000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4319000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4319000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,149000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,255000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3035000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1832000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2712000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2712000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,559000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-621000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-51417000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51160000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-319000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-319000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2412000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4556000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2144000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2144000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5175000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5319000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5319000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,147000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,241000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4823000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2285000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2393000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2393000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1084000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-39423000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58955000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18448000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18448000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3178000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3171000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3171000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:29:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19226000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12126000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12126000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,281000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,223000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2883000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,714000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8025000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8025000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-998000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-81472000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,74280000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8190000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8190000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1727000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1727000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14488000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9245000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9245000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,317000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,217000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2828000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8315000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14198000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14198000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-245000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47732000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69940000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21963000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21963000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15754000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15754000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23519000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14013000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14013000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,243000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,146000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3066000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1454000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9104000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9104000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,2327000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2411000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-89361000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,134686000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,45241000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,45241000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-942000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-942000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35195000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16494000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16494000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,245000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,72000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3194000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7377000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20360000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20360000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-252000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84816000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68770000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16298000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16298000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,187000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,185000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,185000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:56:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-36473000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26575000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26575000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,248000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,61000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7199000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2890000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16177000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16177000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-104000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61074000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,57317000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3861000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3861000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,516000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-532000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-16000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-16000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20054000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18965000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18965000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,252000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-292000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3215000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1768000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17578000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17578000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-153000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42239000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,74410000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,32018000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,32018000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,534000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,591000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,591000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15031000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9624000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9624000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,252000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,380000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1548000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4344000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11768000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11768000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-223000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30511000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37000000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6266000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6266000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,353000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-776000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-423000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-423000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5925000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16632000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16632000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,301000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,60000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2860000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,333000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13078000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13078000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-468000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38973000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45500000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6059000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6059000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3425000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3444000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3444000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 21:57:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3575000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12491000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12491000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,317000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-28000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1891000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,67097000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,56786000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,56786000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1707000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-120193000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37529000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-84371000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-84371000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,78137000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,802000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,78950000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,78936000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,51351000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12354000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12354000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,412000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-342000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2147000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5550000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15687000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15687000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-698000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-70429000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44064000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27063000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27063000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,11000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2789000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2793000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2807000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-39943000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13091000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13091000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,468000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-363000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2283000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6139000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16842000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16842000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-878000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22733000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51582000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,27971000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,27971000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12957000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-654000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12303000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12303000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23432000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20187000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20187000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,588000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-459000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3267000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1343000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18134000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18134000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2616000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-63401000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54450000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11567000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11567000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10597000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10611000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10583000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:34:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-19118000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16640000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16640000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,619000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1197000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3762000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,135897000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,122441000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,122441000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3152000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-387839000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,78847000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-312144000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-312144000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,218444000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,43000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,218487000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,218401000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28698000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12843000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12843000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,461000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-2387000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4060000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16887000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27596000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27596000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9260000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5220000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97250000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,82770000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,82770000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1159000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,56333000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19219000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19219000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,691000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1786000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4554000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24401000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-40161000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-40161000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28037000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-75647000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,5221000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,161298000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,62835000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,62835000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1566000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24240000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42203000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42203000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,715000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1238000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4956000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7349000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-45119000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-45119000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5977000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-87075000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,78253000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14799000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14799000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,481000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-265000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,216000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,216000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:27:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-59702000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30356000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30356000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,868000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1217000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5472000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14360000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-39593000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-39593000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3783000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-157231000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,148631000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12383000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12383000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,139921000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,561000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,140482000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,139890000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,87914000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27361000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27361000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1159000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1260000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6240000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17652000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38874000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38874000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4134000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77084000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,65263000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-262000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16217000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16217000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,704000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-54387000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4501000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4501000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1188000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-993000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6337000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31849000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20816000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20816000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6781000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-122321000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,112700000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16402000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16402000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,136308000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-135055000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-34000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1219000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1219000.0
Sangamo Therapeutics Inc,SGMO,,0001001233,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-35999000.0
